Osteoarthritis is one of the most common causes of chronic joint pain, stiffness, and reduced mobility worldwide. Over time, everyday activities such as walking, climbing stairs, or exercising may become increasingly difficult.
In recent years, stem cell therapy for osteoarthritis has gained significant attention within regenerative medicine as patients seek non-surgical options to help improve joint function and quality of life.¹⁻¹⁵
What Is Osteoarthritis?
Osteoarthritis is a degenerative joint disease characterized by progressive cartilage breakdown, inflammation, and reduced joint function. Common symptoms include:
- Chronic joint pain
- Stiffness
- Swelling
- Reduced range of motion
- Difficulty with physical activity
Traditional treatments may include physical therapy, medications, exercise programs, injections, and surgery in advanced cases. However, many patients continue searching for alternatives that may help support mobility and long-term joint health.¹⁻⁴
What Are Mesenchymal Stem Cells?
Mesenchymal stem cells (MSCs) are specialized cells studied for their regenerative and anti-inflammatory properties. Researchers continue investigating how MSCs may help support tissue repair, regulate inflammation, and improve joint function.⁵⁻⁸
Current studies have evaluated MSCs derived from:
- Bone marrow
- Adipose tissue
- Synovial tissue
- Umbilical cord-derived tissues
Research suggests MSCs may influence healing processes through immune modulation, growth factor secretion, and interaction with cartilage and joint tissues.⁵⁻¹⁰
What Does Current Research Show?
Scientific evidence surrounding stem cell therapy for osteoarthritis includes systematic reviews, randomized clinical trials, and meta-analyses.¹⁻¹⁵
Several studies have reported improvements in pain, mobility, and knee function following MSC therapy. Meta-analyses have demonstrated reductions in pain scores and improvements in functional outcomes such as WOMAC, Lysholm, and IKDC scores.²˒³˒¹⁵ Some studies suggest benefits may last between 12 and 24 months.²˒¹⁵
Research has also explored differences between cell sources and preparation methods. Some analyses suggest bone marrow-derived MSCs and cultured MSC preparations may provide improved outcomes, although treatment protocols remain variable between studies.⁹
A 2025 Cochrane review emphasized the need for continued high-quality research and standardized clinical methodologies.⁴ While symptomatic improvement has been observed, evidence supporting consistent structural cartilage regeneration remains limited.⁴
Why Does Cartilage Regeneration Matter?
Articular cartilage protects the joints and allows smooth movement between bones. Because cartilage has limited natural healing capacity, regenerative medicine strategies continue to be actively studied.
Current research suggests stem cell therapy may help support joint homeostasis, reduce inflammation, and potentially influence cartilage repair processes.⁵⁻⁸ However, researchers are still investigating whether the primary benefits result from direct cartilage regeneration or from anti-inflammatory and immunomodulatory effects within the joint.⁴˒¹⁰
What Have Clinical Studies Found?
Randomized controlled trials evaluating MSC-based therapies for osteoarthritis have generally demonstrated favorable safety profiles and improvements in pain and function.¹¹⁻¹³
The most commonly reported side effects include:
- Temporary discomfort at the injection site
- Mild swelling
- Short-term pain flare
- Temporary stiffness
Most adverse events reported in clinical studies have been mild and self-limiting.⁴˒⁶
The Importance of Rehabilitation
Rehabilitation and recovery programs may play an important role in optimizing outcomes after regenerative therapy.¹⁰ Comprehensive patient care may include:
- Physical therapy
- Mobility exercises
- Strengthening programs
- Weight management
- Medical follow-up
- Important Considerations for Patients
Clinical guidelines continue evolving as regenerative medicine research advances. Current evidence suggests stem cell therapy may help support symptom relief and functional improvement in selected patients, particularly in earlier stages of osteoarthritis.⁶˒¹⁴
However, stem cell therapy should not currently be considered a guaranteed cure for osteoarthritis. Appropriate medical evaluation, individualized treatment planning, and physician oversight remain essential.⁴˒¹³
Stemwell’s Commitment to Regenerative Medicine
At Stemwell, we believe patients deserve access to evidence-based regenerative medicine supported by scientific research, personalized care, and comprehensive medical evaluation.
Our team focuses on patient-centered treatment strategies designed to support joint health, mobility, recovery, and quality of life. As a leading clinic in stem cell therapy and regenerative medicine, Stemwell remains committed to maintaining high medical standards and science-driven care.
Final Thoughts
Stem cell therapy for osteoarthritis remains a rapidly evolving field within regenerative medicine. Current evidence suggests MSC-based therapies may help improve pain, mobility, and joint function in selected patients, although additional research is still needed to better define long-term outcomes and cartilage regeneration.
Patients considering regenerative therapies should seek evaluation from qualified medical professionals experienced in regenerative medicine, orthopedics, and rehabilitation.
References
- McIntyre JA, Jones IA, Han B, Vangsness CT. Intra-articular mesenchymal stem cell therapy for the human joint: a systematic review. Am J Sports Med. 2018.
- Xie RH, Gong SG, Song J, Wu PP, Hu WL. Effect of mesenchymal stromal cells transplantation on the outcomes of patients with knee osteoarthritis: a systematic review and meta-analysis. J Orthop Res. 2024.
- Awad G, Saad JP, Hamyeh A, Boutros M. Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Clin Rheumatol. 2026.
- Whittle SL, Johnston RV, McDonald S, et al. Stem cell injections for osteoarthritis of the knee. Cochrane Database Syst Rev. 2025.
- Jiang S, Tian G, Li X, et al. Research progress on stem cell therapies for articular cartilage regeneration. Stem Cells Int. 2020.
- Xu X, Xu L, Xia J, et al. Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering. Acta Biomater. 2023.
- Colombini A, Perucca Orfei C, Kouroupis D, et al. Mesenchymal stem cells in the treatment of articular cartilage degeneration: new biological insights for an old-timer cell. Cytotherapy. 2019.
- De Bari C, Roelofs AJ. Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis. Curr Opin Pharmacol. 2018.
- Tan SHS, Kwan YT, Neo WJ, et al. Intra-articular injections of mesenchymal stem cells without adjuvant therapies for knee osteoarthritis: a systematic review and meta-analysis. Am J Sports Med. 2021.
- Cottmeyer DF, Chiu M, Maltusch K, Tsai LC. Towards optimized rehabilitation with regenerative therapy: a systematic review and meta-analysis on the effects of cell-based injections for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2026.
- Kim KI, Lee MC, Lee JH, et al. Clinical efficacy and safety of the intra-articular injection of autologous adipose-derived mesenchymal stem cells for knee osteoarthritis: a phase III, randomized, double-blind, placebo-controlled trial. Am J Sports Med. 2023.
- Gupta PK, Maheshwari S, Cherian JJ, et al. Efficacy and safety of Stempeucel in osteoarthritis of the knee: a phase 3 randomized, double-blind, multicenter, placebo-controlled study. Am J Sports Med. 2023.
- Wiggers TG, Winters M, Van den Boom NA, Haisma HJ, Moen MH. Autologous stem cell therapy in knee osteoarthritis: a systematic review of randomised controlled trials. Br J Sports Med. 2021.
- Hunter CW, Deer TR, Jones MR, et al. Consensus guidelines on interventional therapies for knee pain (STEP Guidelines) from the American Society of Pain and Neuroscience. J Pain Res. 2022.
- Long Z, Zhang M, Zhang T, et al. The effectiveness and safety of mesenchymal stem cells in the treatment of osteoarthritis: a systematic review and meta-analysis of 28 randomized controlled trials. Stem Cells Int. 2022.
Ready to learn more about stem cell therapy?
At Stemwell, our team of doctors are highly skilled in successfully supporting thousands of people with a range of stem cell treatments. If you would like to learn more about stem cell therapy you can contact us with any questions, or apply today to check your eligibility.
